inpefa drug：FDA Approves Inpefa as First Dual Heart Failure Medication

FDA Approves Inpefa as First Dual Heart Failure Medication

2023年5月30日—Inpefa(sotagliflozin)wasrecentlyapprovedbytheFDAforheartfailure.Intrialresults,sotagliflozinwasshowntolowertheriskof ...。其他文章還包含有：「INPEFAcancauseserioussideeffects」、「InpefaOral:Uses,SideEffects,Interactions」、「Inpefa」、「Inpefa」、「Inpefa:Uses,Dosage」、「INPEFATM(sotagliflozin)tablets」、「LexiconfinallyscoresFDAnodforheartfailuredrugInpefa」、「NowApproved」、...

查看更多離開網站

Provide From Google

INPEFA can cause serious side effects

https://dailymed.nlm.nih.gov

INPEFA is a prescription medicine used to reduce the risk of death due to heart problems (cardiovascular death), hospitalization for heart failure, and urgent ...

Provide From Google

Inpefa Oral: Uses, Side Effects, Interactions

https://www.webmd.com

Sotagliflozin is used by people with heart failure or by people with type 2 diabetes, kidney disease, and other heart disease risk factors to lower the risk ...

Provide From Google

Inpefa

https://www.managedhealthcaree

Inpefa was approved by the FDA on May 26 and is a once-daily oral tablet that reduces the risk of cardiovascular death, hospitalization for ...

Provide From Google

Inpefa

https://www.drugs.com

INPEFA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to reduce the risk of cardiovascular death, hospitalization for heart ...

Provide From Google

Inpefa: Uses, Dosage

https://www.drugs.com

Inpefa is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1), two proteins responsible for glucose regulation.

Provide From Google

INPEFATM (sotagliflozin) tablets

https://www.accessdata.fda.gov

General information about the safe and effective use of INPEFA. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide.

Provide From Google